Large-scale molecular simulations minimise costs and reduce the time it takes to develop bio-based polymer materials 

Click the button below to register
and view a recording of the webinar

Register and view now

Renewable sources have become a valuable asset to industries, driven by the desire for bio-based polymers in consumer packaging, carbon fibre composites and much more. While undeniably positive, this shift in materials production presents unique challenges. For example, how do we expand and build on the experience our teams already have in developing and manufacturing petroleum-based polymers in a way that transfers seamlessly to these new systems?

Molecular simulation presents a way to deal with these adaptations. By providing a critical window into how bio-based polymers behave and allowing effective formulation, there are exciting opportunities for progress, coupled with sizeable time and cost-saving potential.

In this hour-long webinar with industry expert Andrea Browning, we explore how research leaders, material scientists and polymer scientists can learn new techniques for screening and evaluating the performance of bio-based polymer materials.

By watching this webinar you will learn…

  • New digital approaches to bio-based material development
  • How molecular simulations reduce formulation development cycle time
  • To identify key areas in your R&D where molecular simulation can provide value and insight

Portrait photo of Andrea Browning, principal scientist at Schrödinger

Andrea Browning: Product manager, polymers and soft matter

Andrea Browning is responsible for leading efforts related to polymeric materials simulation. Prior to joining Schrödinger in 2017, she was a lead research engineer and project manager at The Boeing Company. She brings over a decade of experience in connecting simulations to industrial decisions. 

Schrodinger Materials 2021 company logo

Schrödinger is transforming the way therapeutics and materials are discovered. The company has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world.

Founded in 1990, Schrödinger has over 650 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn  and Twitter, or visit our blog, Extrapolations.com

Click the button below to register
and view a recording of the webinar

Register and view now